(Q36305931)

13 August 2017

1 reference

title

Review article: how and when to use ciclosporin in ulcerative colitis (English)

1 reference

13 August 2017

1 reference

1 reference

Durai D

1

1 reference

PubMed ID

16268964

13 August 2017

Hawthorne AB

series ordinal

2

1 reference

PubMed ID

16268964

13 August 2017

language of work or name

English

0 references

publication date

1 November 2005

1 reference

Alimentary Pharmacology & Therapeutics

13 August 2017

1 reference

13 August 2017

22

1 reference

13 August 2017

10

1 reference

13 August 2017

907-916

1 reference

Rapid shuttling of NF-AT in discrimination of Ca2+ signals and immunosuppression

13 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Mechanisms of action of cyclosporine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Long-term results of low-dose intravenous ciclosporin for acute severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Oral microemulsion cyclosporine in the treatment of steroid-refractory attacks of ulcerative and indeterminate colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Ciclosporin use in acute ulcerative colitis: a long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Long-term outcome of treatment with intravenous cyclosporin in patients with severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Short- and long-term outcome of patients treated with cyclosporin for severe acute ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Cyclosporin treatment for ulcerative colitis complicated by fatal Pneumocystis carinii pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Cyclosporine-Induced neurotoxicity during treatment of Crohn's disease: lack of correlation with previously reported risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Infliximab as rescue therapy in severe to moderately severe ulcerative colitis: a randomized, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Infliximab in the treatment of severe, steroid-refractory ulcerative colitis: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Morbidity of subtotal colectomy in patients with severe ulcerative colitis unresponsive to cyclosporin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Combination immunomodulatory therapy with cyclosporine and azathioprine in corticosteroid-resistant severe ulcerative colitis: the Edinburgh experience of outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Outcome of a conservative approach in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

Randomized, double-blind comparison of 4 mg/kg versus 2 mg/kg intravenous cyclosporine in severe ulcerative colitis1 1Gert Van Assche, Severine Vermeire, Geert D’Haens, and Paul Rutgeerts have been instrumental in the design of the study, trial man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2005.02680.X

10.1111/J.1365-2036.2005.02680.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16268964